Chevallard Daniel R. - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 27, 2024, Chevallard Daniel R.'s relationship to Viracta Therapeutics, Inc. (VIRX) is Officer (CFO and COO), and currently has 102,306 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VIRX insiders.
Data Source: SEC.
Chevallard Daniel R. - Insider Non-Derivative Transactions of VIRX Common Stock
Chevallard Daniel R. - Insider Non-Derivative Transactions at VIRX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Feb 28, 2024 | Sell -- (Common Stock) | 3405 | 0.73 | 102306 |
Feb 26, 2024 | M -- (Common Stock) | 6889 | 0 | 105711 |
Nov 29, 2023 | Sell -- (Common Stock) | 3720 | 0.5 | 98822 |
Nov 26, 2023 | M -- (Common Stock) | 6889 | 0 | 102542 |
Aug 29, 2023 | Sell -- (Common Stock) | 3512 | 1.45 | 95653 |
Aug 26, 2023 | M -- (Common Stock) | 6888 | 0 | 99165 |
May 26, 2023 | Sell -- (Common Stock) | 3635 | 1.42 | 92277 |
May 26, 2023 | M -- (Common Stock) | 6889 | 0 | 95912 |
Feb 28, 2023 | Sell -- (Common Stock) | 3599 | 1.68 | 89023 |
Feb 26, 2023 | M -- (Common Stock) | 6889 | 0 | 92622 |